Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1962 Jan 31;115(2):383–410. doi: 10.1084/jem.115.2.383

THE ROLE OF IMMUNITY IN THE PATHOGENESIS OF EXPERIMENTAL HEMATOGENOUS PYELONEPHRITIS

Jay P Sanford 1, Betty W Hunter 1, Lona L Souda 1
PMCID: PMC2137485  PMID: 14496914

Abstract

Hematogenous pyelonephritis was produced in rats utilizing multiple strains of Escherichia coli, a strain of Klebsiella pneumoniae, and a strain of Proteus mirabilis. Three patterns of hematogenous pyelonephritis occurred which represent an interrelationship between an immune response to the infecting bacteria and the development of obstructive uropathy as a consequence of infection. First, the course of pyelonephritis due to strains of Escherichia coli was acute, self-limited, and associated with the development of circulating agglutinins. Following healing, this pattern of infection was associated with acquired resistance to reinfection with the same bacterial strain. Second, the course of pyelonephritis due to a strain of Klebsiella pneumoniae type C was chronic. This infection was not associated with the production of circulating agglutinins against encapsulated strains. Acquired resistance to reinfection by the homotypic strain could not be demonstrated following eradication of infection but was produced by the passive transfer of concentrated antiserum. Third, pyelonephritis due to Proteus mirabilis was associated with circulating agglutinins and resistance to reinfection with the same organism following eradication of infection, yet the course was chronic. The chronicity appeared to be the consequence of obstructive uropathy resulting from calculi which developed during the course of the infection. Resistance to reinfection was demonstrated in infections with strains of E. coli and P. mirabilis. The resistance is associated with specific immunity as demonstrated by the observation that: (a) it is type-specific, (b) it is of at least 3 months' duration, and (c) it can be passively transferred by means of rabbit antiserum. Since K. pneumoniae failed to evoke capsular antibodies in the rat, resistance to infection with K. pneumoniae was produced only by means of passively transferred concentrated rabbit antiserum and not by prior infection. Immunity can be demonstrated to have a significant role in the pathogenesis of experimental hematogenous pyelonephritis only in the absence of obstructive uropathy.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABERNATHY R. S. Homologous and heterologous resistance in mice given bacterial endotoxins. J Immunol. 1957 May;78(5):387–394. [PubMed] [Google Scholar]
  2. ANDERSEN B. R., JACKSON G. G. Pyelitis, an important factor in the pathogenesis of retrograde pyelonephritis. J Exp Med. 1961 Sep 1;114:375–384. doi: 10.1084/jem.114.3.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BEESON P. B., ROWLEY D. The anticomplementary effect of kidney tissue; its association with ammonia production. J Exp Med. 1959 Nov 1;110:685–697. doi: 10.1084/jem.110.5.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BRAUDE A. I., SHAPIRO A. P., SIEMIENSKI J. Hematogenous pyelonephritis in rats. I. Its pathogenesis when produced by a simple new method. J Clin Invest. 1955 Oct;34(10):1489–1497. doi: 10.1172/JCI103200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Braude A. I., Siemienski J. The Influence of Endotoxin on Resistance to Infection. Bull N Y Acad Med. 1961 Jul;37(7):448–467. [PMC free article] [PubMed] [Google Scholar]
  6. DUBOS R. J., SCHAEDLER R. W. Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins. J Exp Med. 1956 Jul 1;104(1):53–65. doi: 10.1084/jem.104.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FRETER R. The fatal enteric cholera infection in the guinea pig, achieved by inhibition of normal enteric flora. J Infect Dis. 1955 Jul-Aug;97(1):57–65. doi: 10.1093/infdis/97.1.57. [DOI] [PubMed] [Google Scholar]
  8. GAINES S., LANDY M., EDSALL G., MANDEL A. D., TRAPANI R. J., BENENSON A. S. Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization. J Exp Med. 1961 Sep 1;114:327–342. doi: 10.1084/jem.114.3.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hughes W. H. Failure of Immunity Responses in Localized Disease. Br Med J. 1945 Mar 17;1(4393):366–368. doi: 10.1136/bmj.1.4393.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LANDY M., JOHNSON A. G., WEBSTER M. E., SAGIN J. F. Studies on the O antigen of Salmonella typhosa. II. Immunological properties of the purified antigen. J Immunol. 1955 Jun;74(6):466–478. [PubMed] [Google Scholar]
  11. LANDY M., PILLEMER L. Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides. J Exp Med. 1956 Sep 1;104(3):383–409. doi: 10.1084/jem.104.3.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MCCABE W. R. Tolerance to bacterial endotoxin produced by proliferation of gram negative bacteria in the kidney. Proc Soc Exp Biol Med. 1961 Jun;107:402–404. doi: 10.3181/00379727-107-26639. [DOI] [PubMed] [Google Scholar]
  13. NEEDELL M. H., NETER E., STAUBITZ W. J., BINGHAM W. A. The antibody (hemagglutinin) response of patients with infections of the urinary tract. J Urol. 1955 Nov;74(5):674–682. doi: 10.1016/S0022-5347(17)67336-1. [DOI] [PubMed] [Google Scholar]
  14. NOYES H. E., PULASKI E. J., BALCH H. H. The detection of bacterial endotoxins in the plasma of dogs with experimental peritonitis. Ann Surg. 1956 Jul;144(1):51–56. doi: 10.1097/00000658-195607000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. WEYRAUCH H. M., ROSENBERG M. L., AMAR A. D., REDOR M. Effects of antibiotics and vaccination on experimental pyelonephritis. J Urol. 1957 Nov;78(5):532–539. doi: 10.1016/S0022-5347(17)66474-7. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES